Systemic inflammation markers and the prevalence of hypertension: A NHANES cross-sectional study

Systemic inflammation markers have been highlighted recently as related to cardiac and non-cardiac disorders. However, few studies have estimated pre-diagnostic associations between these markers and hypertension. In the National Health and Nutritional Examination Survey from 1999 to 2010, 22,290 ad...

Full description

Saved in:
Bibliographic Details
Published inHypertension research Vol. 46; no. 4; pp. 1009 - 1019
Main Authors Xu, Jun-Peng, Zeng, Rui-Xiang, Zhang, Yu-Zhuo, Lin, Shan-Shan, Tan, Jia-Wei, Zhu, Hai-Yue, Mai, Xiao-Yi, Guo, Li-Heng, Zhang, Min-Zhou
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 01.04.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Systemic inflammation markers have been highlighted recently as related to cardiac and non-cardiac disorders. However, few studies have estimated pre-diagnostic associations between these markers and hypertension. In the National Health and Nutritional Examination Survey from 1999 to 2010, 22,290 adult participants were included for analysis. We assessed associations between four systemic inflammation markers based on blood cell counts: systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), and hypertension prevalence in multivariate logistic regression analysis with odds ratio (OR) and 95% confidence interval (CI). To further explore their associations, subgroup and sensitivity analyses were performed. In continuous analyses, the ORs for hypertension prevalence per ln-transformed increment in SII and NLR were estimated at 1.115 and 1.087 (95% CI: 1.045-1.188; 1.008-1.173; respectively). Compared to those in the lowest tertiles, the hypertension risks for subjects in the highest SII and NLR tertiles were 1.20 and 1.11 times, respectively. Conversely, we found that PLR and LMR were negatively associated with hypertension prevalence in continuous analyses (1.060, 0.972-1.157; 0.926, 0.845-1.014; respectively), and the highest PLR and LMR tertiles (1.041, 0.959-1.129; 0.943, 0.866-1.028; respectively). Also, subgroup and sensitivity analyses indicated that SII had a greater correlation to hypertension. In conclusion, we find positive associations between SII and NLR and the prevalence of hypertension in this cross-sectional study. Our findings highlight that SII may be a superior systemic inflammation warning marker for hypertension.
AbstractList Systemic inflammation markers have been highlighted recently as related to cardiac and non-cardiac disorders. However, few studies have estimated pre-diagnostic associations between these markers and hypertension. In the National Health and Nutritional Examination Survey from 1999 to 2010, 22,290 adult participants were included for analysis. We assessed associations between four systemic inflammation markers based on blood cell counts: systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), and hypertension prevalence in multivariate logistic regression analysis with odds ratio (OR) and 95% confidence interval (CI). To further explore their associations, subgroup and sensitivity analyses were performed. In continuous analyses, the ORs for hypertension prevalence per ln-transformed increment in SII and NLR were estimated at 1.115 and 1.087 (95% CI: 1.045-1.188; 1.008-1.173; respectively). Compared to those in the lowest tertiles, the hypertension risks for subjects in the highest SII and NLR tertiles were 1.20 and 1.11 times, respectively. Conversely, we found that PLR and LMR were negatively associated with hypertension prevalence in continuous analyses (1.060, 0.972-1.157; 0.926, 0.845-1.014; respectively), and the highest PLR and LMR tertiles (1.041, 0.959-1.129; 0.943, 0.866-1.028; respectively). Also, subgroup and sensitivity analyses indicated that SII had a greater correlation to hypertension. In conclusion, we find positive associations between SII and NLR and the prevalence of hypertension in this cross-sectional study. Our findings highlight that SII may be a superior systemic inflammation warning marker for hypertension.
Systemic inflammation markers have been highlighted recently as related to cardiac and non-cardiac disorders. However, few studies have estimated pre-diagnostic associations between these markers and hypertension. In the National Health and Nutritional Examination Survey from 1999 to 2010, 22,290 adult participants were included for analysis. We assessed associations between four systemic inflammation markers based on blood cell counts: systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), and hypertension prevalence in multivariate logistic regression analysis with odds ratio (OR) and 95% confidence interval (CI). To further explore their associations, subgroup and sensitivity analyses were performed. In continuous analyses, the ORs for hypertension prevalence per ln-transformed increment in SII and NLR were estimated at 1.115 and 1.087 (95% CI: 1.045-1.188; 1.008-1.173; respectively). Compared to those in the lowest tertiles, the hypertension risks for subjects in the highest SII and NLR tertiles were 1.20 and 1.11 times, respectively. Conversely, we found that PLR and LMR were negatively associated with hypertension prevalence in continuous analyses (1.060, 0.972-1.157; 0.926, 0.845-1.014; respectively), and the highest PLR and LMR tertiles (1.041, 0.959-1.129; 0.943, 0.866-1.028; respectively). Also, subgroup and sensitivity analyses indicated that SII had a greater correlation to hypertension. In conclusion, we find positive associations between SII and NLR and the prevalence of hypertension in this cross-sectional study. Our findings highlight that SII may be a superior systemic inflammation warning marker for hypertension.Systemic inflammation markers have been highlighted recently as related to cardiac and non-cardiac disorders. However, few studies have estimated pre-diagnostic associations between these markers and hypertension. In the National Health and Nutritional Examination Survey from 1999 to 2010, 22,290 adult participants were included for analysis. We assessed associations between four systemic inflammation markers based on blood cell counts: systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), and hypertension prevalence in multivariate logistic regression analysis with odds ratio (OR) and 95% confidence interval (CI). To further explore their associations, subgroup and sensitivity analyses were performed. In continuous analyses, the ORs for hypertension prevalence per ln-transformed increment in SII and NLR were estimated at 1.115 and 1.087 (95% CI: 1.045-1.188; 1.008-1.173; respectively). Compared to those in the lowest tertiles, the hypertension risks for subjects in the highest SII and NLR tertiles were 1.20 and 1.11 times, respectively. Conversely, we found that PLR and LMR were negatively associated with hypertension prevalence in continuous analyses (1.060, 0.972-1.157; 0.926, 0.845-1.014; respectively), and the highest PLR and LMR tertiles (1.041, 0.959-1.129; 0.943, 0.866-1.028; respectively). Also, subgroup and sensitivity analyses indicated that SII had a greater correlation to hypertension. In conclusion, we find positive associations between SII and NLR and the prevalence of hypertension in this cross-sectional study. Our findings highlight that SII may be a superior systemic inflammation warning marker for hypertension.
Author Xu, Jun-Peng
Tan, Jia-Wei
Zhang, Min-Zhou
Zeng, Rui-Xiang
Zhang, Yu-Zhuo
Zhu, Hai-Yue
Lin, Shan-Shan
Mai, Xiao-Yi
Guo, Li-Heng
Author_xml – sequence: 1
  givenname: Jun-Peng
  surname: Xu
  fullname: Xu, Jun-Peng
– sequence: 2
  givenname: Rui-Xiang
  surname: Zeng
  fullname: Zeng, Rui-Xiang
– sequence: 3
  givenname: Yu-Zhuo
  surname: Zhang
  fullname: Zhang, Yu-Zhuo
– sequence: 4
  givenname: Shan-Shan
  surname: Lin
  fullname: Lin, Shan-Shan
– sequence: 5
  givenname: Jia-Wei
  surname: Tan
  fullname: Tan, Jia-Wei
– sequence: 6
  givenname: Hai-Yue
  surname: Zhu
  fullname: Zhu, Hai-Yue
– sequence: 7
  givenname: Xiao-Yi
  surname: Mai
  fullname: Mai, Xiao-Yi
– sequence: 8
  givenname: Li-Heng
  surname: Guo
  fullname: Guo, Li-Heng
– sequence: 9
  givenname: Min-Zhou
  surname: Zhang
  fullname: Zhang, Min-Zhou
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36707716$$D View this record in MEDLINE/PubMed
BookMark eNp9kTtPHDEUha2IKCwLfyAFskRD4-T6OWO6FYIQCZGCUBuv944YMo_F9iDtv8e7Cw1Fqtt85-jcc47IwTAOSMh3Dj84yPpnUlwpYCAkA86tZvCFzLhUNVOCqwMyA8sNs0aaQ3KU0jOAqLXl38ihNBVUFTcz8ni_SRn7NtB2aDrf9z6340B7H_9hTNQPK5qfkK4jvvoOh4B0bOjTZo0x45AKekEX9O5mcXd1T0McU2IJw9bCdzTlabU5Jl8b3yU8eb9z8nB99ffyht3--fX7cnHLgtQ6MwsrqzUopWVJBk2jlC3faVgaoSohJVfWKq2MqpqwxFqgrqTxWshgsA5Bzsn53ncdx5cJU3Z9mwJ2nR9wnJITxVVVVlpb0LNP6PM4xZJ4S1kNJUjxnZPTd2pa9rhy69iWVjbuo7sC1Htg93fExoU27-rL0bed4-C2M7n9TK7M5HYzOShS8Un64f4f0RswkpIQ
CitedBy_id crossref_primary_10_1038_s41390_024_03633_2
crossref_primary_10_1080_17520363_2024_2412515
crossref_primary_10_18705_1607_419X_2024_2405
crossref_primary_10_1097_HJH_0000000000003560
crossref_primary_10_1016_j_numecd_2023_09_025
crossref_primary_10_1038_s41598_024_62280_z
crossref_primary_10_1186_s12877_023_04635_1
crossref_primary_10_3389_fendo_2023_1307692
crossref_primary_10_1186_s40001_025_02473_y
crossref_primary_10_1016_j_jstrokecerebrovasdis_2024_108076
crossref_primary_10_2174_0115701611297956240425115501
crossref_primary_10_1016_j_talanta_2025_127882
crossref_primary_10_1016_j_numecd_2024_08_020
crossref_primary_10_1016_j_chemosphere_2024_142626
crossref_primary_10_3389_fendo_2024_1436999
crossref_primary_10_3389_fnut_2025_1536488
crossref_primary_10_3390_ijms26030868
crossref_primary_10_31083_RCM25055
crossref_primary_10_3389_fpsyt_2024_1488487
crossref_primary_10_7759_cureus_70072
crossref_primary_10_1111_prd_12612
crossref_primary_10_1038_s41371_024_00975_6
crossref_primary_10_1371_journal_pone_0296936
crossref_primary_10_2147_IJWH_S492712
crossref_primary_10_3389_fimmu_2024_1323174
crossref_primary_10_1007_s00784_024_05529_1
crossref_primary_10_1016_j_numecd_2024_06_003
crossref_primary_10_18332_tid_195397
crossref_primary_10_1038_s41598_024_53077_1
crossref_primary_10_1097_MD_0000000000038810
crossref_primary_10_1016_j_wneu_2024_02_001
crossref_primary_10_3389_fpubh_2025_1526360
crossref_primary_10_2147_JIR_S459238
crossref_primary_10_1186_s12865_025_00690_y
crossref_primary_10_1097_MD_0000000000039341
crossref_primary_10_3389_fnut_2024_1374992
crossref_primary_10_3390_medicina60030442
crossref_primary_10_1038_s41440_023_01212_2
crossref_primary_10_1016_j_ejphar_2024_177008
crossref_primary_10_1038_s41467_023_42758_6
crossref_primary_10_2147_JIR_S432506
crossref_primary_10_1038_s41569_023_00964_1
crossref_primary_10_1093_ajh_hpae043
crossref_primary_10_3389_fnut_2024_1470833
crossref_primary_10_1038_s41440_023_01477_7
crossref_primary_10_1186_s40001_024_01736_4
crossref_primary_10_1016_j_scitotenv_2024_173657
crossref_primary_10_1111_jcpe_13876
crossref_primary_10_2147_COPD_S497829
crossref_primary_10_3390_life13030640
crossref_primary_10_1007_s11357_024_01170_8
crossref_primary_10_1016_j_ocarto_2024_100496
crossref_primary_10_1097_MCA_0000000000001454
crossref_primary_10_1016_j_heliyon_2024_e27517
crossref_primary_10_1186_s12944_024_02111_2
crossref_primary_10_1016_j_jep_2024_118471
crossref_primary_10_1186_s13690_023_01190_4
crossref_primary_10_1038_s41390_024_03472_1
crossref_primary_10_1186_s12933_024_02191_5
crossref_primary_10_1016_j_heliyon_2024_e31524
crossref_primary_10_1186_s12889_024_17699_4
crossref_primary_10_1002_JPER_23_0260
crossref_primary_10_1186_s12872_023_03661_6
crossref_primary_10_12677_ACM_2023_132392
crossref_primary_10_2147_JIR_S433843
Cites_doi 10.1161/CIRCULATIONAHA.110.992362
10.1373/clinchem.2016.260828
10.3748/wjg.v23.i34.6261
10.1681/ASN.2006070707
10.1111/j.1538-7836.2011.04425.x
10.1038/s41390-022-02056-1
10.3389/fcvm.2021.743075
10.1161/JAHA.119.013470
10.1152/ajprenal.00507.2006
10.1161/CIR.0000000000000485
10.1038/ajh.2011.32
10.3389/fonc.2018.00078
10.1111/jch.13286
10.1136/heartjnl-2018-314216
10.1161/CIRCRESAHA.116.303641
10.1093/eurheartj/ehy339
10.1161/HYPERTENSIONAHA.119.13642
10.1161/CIRCRESAHA.121.318082
10.1038/s41440-019-0245-3
10.1038/s41598-019-39150-0
10.1016/S0140-6736(14)60685-1
10.1080/10641963.2021.1916944
10.1093/ajh/hpv034
10.1007/s10654-021-00752-6
10.1038/s41591-019-0675-0
10.7326/0003-4819-150-9-200905050-00006
10.1016/j.jash.2012.11.007
10.1016/j.recesp.2020.11.026
10.1136/bjsports-2020-102955
10.1016/j.atherosclerosis.2021.02.012
10.3389/fimmu.2022.863640
10.1161/01.HYP.0000049761.98155.7B
10.7326/0003-4819-139-9-200311040-00011
10.1186/s40885-015-0036-3
10.1016/S0140-6736(17)32814-3
ContentType Journal Article
Copyright 2023. The Author(s), under exclusive licence to The Japanese Society of Hypertension.
The Author(s), under exclusive licence to The Japanese Society of Hypertension 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Copyright_xml – notice: 2023. The Author(s), under exclusive licence to The Japanese Society of Hypertension.
– notice: The Author(s), under exclusive licence to The Japanese Society of Hypertension 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
DOI 10.1038/s41440-023-01195-0
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
ProQuest One Academic Middle East (New)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1348-4214
EndPage 1019
ExternalDocumentID 36707716
10_1038_s41440_023_01195_0
Genre Journal Article
GroupedDBID ---
0R~
29I
39C
4.4
406
5GY
70F
7X7
88E
8FI
8FJ
AACDK
AANZL
AASML
AATNV
AAYXX
ABAKF
ABBRH
ABDBE
ABFSG
ABJNI
ABLJU
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMFV
ACMJI
ACRQY
ACSTC
ACZOJ
ADBBV
AEFQL
AEJRE
AEMSY
AENEX
AESKC
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AIGIU
AILAN
AIXLP
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
ATHPR
AXYYD
AYFIA
BENPR
BKKNO
BPHCQ
BVXVI
CCPQU
CITATION
CS3
DNIVK
DPUIP
DU5
E3Z
EBLON
EBS
EE.
EIOEI
EJD
F5P
FDQFY
FERAY
FIGPU
FSGXE
FYUFA
GX1
HMCUK
HZ~
IWAJR
JSH
JSO
JZLTJ
LGEZI
LOTEE
M1P
NADUK
NQJWS
NXXTH
O9-
OK1
P2P
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
RNT
RNTTT
ROL
SNX
SNYQT
SOHCF
SOJ
SRMVM
SWTZT
TAOOD
TBHMF
TDRGL
TSG
UKHRP
XSB
-Q-
.55
2WC
53G
ABAWZ
BAWUL
CGR
CUY
CVF
DIK
ECM
EIF
EMB
EMOBN
FIZPM
JSF
KQ8
NPM
RJT
RZJ
SV3
TKC
TR2
W2D
X7M
3V.
7XB
8FK
ABRTQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PUEGO
7X8
ID FETCH-LOGICAL-c355t-90d955044530770ff44914450b62472331499454647fcbe82e5736a523c6e8cc3
IEDL.DBID 7X7
ISSN 0916-9636
1348-4214
IngestDate Fri Jul 11 11:23:08 EDT 2025
Sat Aug 23 14:09:21 EDT 2025
Thu Apr 03 07:08:01 EDT 2025
Tue Jul 01 04:12:32 EDT 2025
Thu Apr 24 23:44:04 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Systemic inflammation index
NHANES
Blood-based inflammation markers
Hypertension prevalence
Language English
License 2023. The Author(s), under exclusive licence to The Japanese Society of Hypertension.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c355t-90d955044530770ff44914450b62472331499454647fcbe82e5736a523c6e8cc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 36707716
PQID 2795095552
PQPubID 2043497
PageCount 11
ParticipantIDs proquest_miscellaneous_2770479399
proquest_journals_2795095552
pubmed_primary_36707716
crossref_citationtrail_10_1038_s41440_023_01195_0
crossref_primary_10_1038_s41440_023_01195_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-04-01
PublicationDateYYYYMMDD 2023-04-01
PublicationDate_xml – month: 04
  year: 2023
  text: 2023-04-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Tokyo
PublicationTitle Hypertension research
PublicationTitleAlternate Hypertens Res
PublicationYear 2023
Publisher Nature Publishing Group
Publisher_xml – name: Nature Publishing Group
References JL Sylman (1195_CR9) 2018; 8
TD Giles (1195_CR28) 2018; 20
EJ Benjamin (1195_CR19) 2017; 135
M Coppo (1195_CR34) 2011; 24
A Pelliccia (1195_CR13) 2021; 74
JH Chen (1195_CR24) 2017; 23
K Sliwa (1195_CR1) 2011; 123
DG Harrison (1195_CR4) 2021; 128
PC Chiu (1195_CR29) 2021; 8
PK Whelton (1195_CR17) 2018; 71
ÖF Çırakoğlu (1195_CR21) 2021; 43
YJ Song (1195_CR7) 2016; 22
AS Levey (1195_CR16) 2009; 150
A Jayedi (1195_CR23) 2019; 105
AM Rothman (1195_CR5) 2020; 75
S Oparil (1195_CR27) 2003; 139
H Huang (1195_CR20) 2019; 9
FC Bull (1195_CR14) 2020; 54
JI Borissoff (1195_CR32) 2011; 9
GY Lip (1195_CR31) 2003; 41
TH Nøst (1195_CR11) 2021; 36
YH Jhuang (1195_CR6) 2019; 42
Z Wu (1195_CR8) 2017; 63
E Rapsomaniki (1195_CR2) 2014; 383
B Williams (1195_CR3) 2018; 39
A Zanchetti (1195_CR26) 2015; 116
X Jiang (1195_CR30) 2020; 9
Z Qin (1195_CR22) 2022; 13
1195_CR12
DG Harrison (1195_CR35) 2013; 7
X Liu (1195_CR18) 2015; 28
D Furman (1195_CR25) 2019; 25
M Jurewicz (1195_CR33) 2007; 18
M Xu (1195_CR10) 2021; 323
PM Ridker (1195_CR37) 2018; 391
M Heron (1195_CR15) 2015; 64
Y Bravo (1195_CR36) 2007; 293
36759664 - Hypertens Res. 2023 Feb 9
References_xml – volume: 123
  start-page: 2892
  year: 2011
  ident: 1195_CR1
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.110.992362
– volume: 63
  start-page: 663
  year: 2017
  ident: 1195_CR8
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2016.260828
– volume: 71
  start-page: e13
  year: 2018
  ident: 1195_CR17
  publication-title: Hypertension
– volume: 23
  start-page: 6261
  year: 2017
  ident: 1195_CR24
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v23.i34.6261
– volume: 18
  start-page: 1093
  year: 2007
  ident: 1195_CR33
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2006070707
– volume: 9
  start-page: 1791
  year: 2011
  ident: 1195_CR32
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2011.04425.x
– ident: 1195_CR12
  doi: 10.1038/s41390-022-02056-1
– volume: 64
  start-page: 1
  year: 2015
  ident: 1195_CR15
  publication-title: Natl Vital- Stat Rep
– volume: 8
  start-page: 743075
  year: 2021
  ident: 1195_CR29
  publication-title: Front Cardiovasc Med.
  doi: 10.3389/fcvm.2021.743075
– volume: 9
  start-page: e013470
  year: 2020
  ident: 1195_CR30
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.119.013470
– volume: 293
  start-page: F616
  year: 2007
  ident: 1195_CR36
  publication-title: Am J Physiol Ren Physiol
  doi: 10.1152/ajprenal.00507.2006
– volume: 135
  start-page: e146
  year: 2017
  ident: 1195_CR19
  publication-title: Circulation
  doi: 10.1161/CIR.0000000000000485
– volume: 24
  start-page: 716
  year: 2011
  ident: 1195_CR34
  publication-title: Am J Hypertens
  doi: 10.1038/ajh.2011.32
– volume: 8
  start-page: 78
  year: 2018
  ident: 1195_CR9
  publication-title: Front Oncol
  doi: 10.3389/fonc.2018.00078
– volume: 20
  start-page: 840
  year: 2018
  ident: 1195_CR28
  publication-title: J Clin Hypertens
  doi: 10.1111/jch.13286
– volume: 105
  start-page: 686
  year: 2019
  ident: 1195_CR23
  publication-title: Heart
  doi: 10.1136/heartjnl-2018-314216
– volume: 116
  start-page: 1058
  year: 2015
  ident: 1195_CR26
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.116.303641
– volume: 39
  start-page: 3021
  year: 2018
  ident: 1195_CR3
  publication-title: Eur Heart J.
  doi: 10.1093/eurheartj/ehy339
– volume: 75
  start-page: 477
  year: 2020
  ident: 1195_CR5
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.119.13642
– volume: 128
  start-page: 847
  year: 2021
  ident: 1195_CR4
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.121.318082
– volume: 42
  start-page: 1209
  year: 2019
  ident: 1195_CR6
  publication-title: Hypertens Res
  doi: 10.1038/s41440-019-0245-3
– volume: 9
  year: 2019
  ident: 1195_CR20
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-39150-0
– volume: 383
  start-page: 1899
  year: 2014
  ident: 1195_CR2
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(14)60685-1
– volume: 43
  start-page: 565
  year: 2021
  ident: 1195_CR21
  publication-title: Clin Exp Hypertens
  doi: 10.1080/10641963.2021.1916944
– volume: 28
  start-page: 1339
  year: 2015
  ident: 1195_CR18
  publication-title: Am J Hypertens
  doi: 10.1093/ajh/hpv034
– volume: 36
  start-page: 841
  year: 2021
  ident: 1195_CR11
  publication-title: Eur J Epidemiol
  doi: 10.1007/s10654-021-00752-6
– volume: 25
  start-page: 1822
  year: 2019
  ident: 1195_CR25
  publication-title: Nat Med
  doi: 10.1038/s41591-019-0675-0
– volume: 150
  start-page: 604
  year: 2009
  ident: 1195_CR16
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-150-9-200905050-00006
– volume: 7
  start-page: 68
  year: 2013
  ident: 1195_CR35
  publication-title: J Am Soc Hypertens
  doi: 10.1016/j.jash.2012.11.007
– volume: 74
  start-page: 545
  year: 2021
  ident: 1195_CR13
  publication-title: Rev Esp Cardiol. (Engl Ed)
  doi: 10.1016/j.recesp.2020.11.026
– volume: 54
  start-page: 1451
  year: 2020
  ident: 1195_CR14
  publication-title: Br J Sports Med
  doi: 10.1136/bjsports-2020-102955
– volume: 323
  start-page: 20
  year: 2021
  ident: 1195_CR10
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2021.02.012
– volume: 13
  start-page: 863640
  year: 2022
  ident: 1195_CR22
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2022.863640
– volume: 41
  start-page: 199
  year: 2003
  ident: 1195_CR31
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000049761.98155.7B
– volume: 139
  start-page: 761
  year: 2003
  ident: 1195_CR27
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-139-9-200311040-00011
– volume: 22
  start-page: 1
  year: 2016
  ident: 1195_CR7
  publication-title: Clin Hypertens
  doi: 10.1186/s40885-015-0036-3
– volume: 391
  start-page: 319
  year: 2018
  ident: 1195_CR37
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)32814-3
– reference: 36759664 - Hypertens Res. 2023 Feb 9;:
SSID ssj0028591
Score 2.5924206
Snippet Systemic inflammation markers have been highlighted recently as related to cardiac and non-cardiac disorders. However, few studies have estimated...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 1009
SubjectTerms Adult
Cross-Sectional Studies
Humans
Hypertension
Hypertension - epidemiology
Inflammation
Lymphocytes
Neutrophils
Nutrition Surveys
Prevalence
Prognosis
Retrospective Studies
Title Systemic inflammation markers and the prevalence of hypertension: A NHANES cross-sectional study
URI https://www.ncbi.nlm.nih.gov/pubmed/36707716
https://www.proquest.com/docview/2795095552
https://www.proquest.com/docview/2770479399
Volume 46
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwEB7BroS4IN4UlpWRuCFrnfiVcEEtalUhbYSAlXoLiWMLJEhK0_3_zDhuVxzYUw5x4mQenhnP-BuAt5l0OfVD4t5njqu2sbzVpeeNbFTnddtm8dT7ZWXWV-rTRm_ShtuYyioPa2JcqLvB0R75RW5LTXBpOv-w_cOpaxRlV1MLjbtwStBlJNV2cxNwETZbxNrLDEdBM-nQjJDFxahiVhMtFo-oZ1z8a5j-421Gq7N6CA-Su8jmE38fwR3fP4Z7lykh_gS-T4jjPx1DSUHmTgcR2W8qutmNrOk7hh4e2-4I1ZuUmA2B_cDYcxcr14f-PZuzaj2vll9Z_C4-xtosmjQizz6Fq9Xy28c1T00TuEPXYc9L0SGVhFIatdeKEJQq8Ve1aE2ubC4lhkSl0sooG1zri9xrK02D8agzvnBOPoOTfuj9C2AmBCmavCu0daoMaLcoh9j6EDoVhDczyA4Uq11CFKfGFr_qmNmWRT1RuUYq15HKtZjBu-Mz2wlP49bRZwdG1Em3xvpGEmbw5ngbtYJSHU3vh2saYwk7H72vGTyfGHicjiDrLIaJL29_-Su4n0fxoCqdMzjZ7679a3RA9u15lLJzOJ2vFosKr4tl9fnLXxBs18Q
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VIgEXVL7KlgJGghOy6jh2nFSqqhW02tLuXmilvaWJYwskSLabrRB_it_IjJNsxYHeeo5jR-Nnz0xm5g3A-yi2kvohceciy1VZGF7qzPEiLlTldFlGoep9OksmF-rLXM834M9QC0NplcOdGC7qqrH0j3xPmkwTXZqWh4srTl2jKLo6tNDoYHHqfv9Cl609OPmM-_tByuOj808T3ncV4BZ164pnosJphFIa4W2E90pl6FVoUSZSGRnH6DNkSqtEGW9Ll0qnTZwU6LDZxKXWxjjvPbiPileQs2fmNw4eccEFbr8o4QjspC_SEXG616oQRUUNyQPLGhf_KsL_WLdByx1vwePePGXjDk9PYMPVT-HBtA_AP4PLjuH8u2WITARTV_jIflKSz7JlRV0xtCjZYkks4nRpsMazb-jrLkOmfFPvszGbTcazo68sfBdvQy4YLRqYbp_DxZ2I8wVs1k3tXgJLvI9FIatUG6syj3qSYpal875SXrhkBNEgsdz2DObUSONHHiLpcZp3Us5RynmQci5G8HH9zqLj77h19O6wEXl_ltv8BnkjeLd-jKeQQitF7ZprGmOIqx-tvRFsdxu4Xo4o8gy6pTu3T_4WHk7Op2f52cns9BU8kgEqlCG0C5ur5bV7jcbPqnwTEMfg8q4h_hdUkw3A
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VrVRxQXyzpYCR4ISsTRw7TpAqtNBdbSmNKqBSb2ni2AIJku1mK8Rf49d1xkkWcaC3nuPY0fjZM5OZeQPwKoyMoH5I3NrQcFkWmpcqtbyICllZVZahr3o_zuLFqfx4ps624M9QC0NplcOd6C_qqjH0j3widKqILk2JievTIk4O5u-WF5w6SFGkdWin0UHkyP7-he5bu394gHv9Woj57OuHBe87DHCDenbN06DCKQMpFUJdB85JmaKHoYIyFlKLKEL_IZVKxlI7U9pEWKWjuEDnzcQ2MSbCeW_BtiavaATb72fZyeeNu0fMcJ7pL4w5wjzuS3aCKJm00sdUUV9yz7nGg3_V4n9sXa_z5nfhTm-ssmmHrnuwZev7sHPch-MfwHnHd_7dMMQpQqsrg2Q_KeVn1bKirhjal2y5Ik5xukJY49g39HxXPm--qd-yKcsW02z2hfnv4q3PDKNFPe_tQzi9EYE-glHd1PYJsNi5KChElShtZOpQa1IEs7TOVdIFNh5DOEgsNz2fObXV-JH7uHqU5J2Uc5Ry7qWcB2N4s3ln2bF5XDt6b9iIvD_Zbf4Xh2N4uXmMZ5ICLUVtm0sao4m5H22_MTzuNnCzHBHmaXRSd6-f_AXsILzzT4fZ0VO4LTxSKF1oD0br1aV9hpbQunzeQ47B-U2j_Art2hNb
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Systemic+inflammation+markers+and+the+prevalence+of+hypertension%3A+A+NHANES+cross-sectional+study&rft.jtitle=Hypertension+research&rft.au=Xu%2C+Jun-Peng&rft.au=Zeng%2C+Rui-Xiang&rft.au=Zhang%2C+Yu-Zhuo&rft.au=Lin%2C+Shan-Shan&rft.date=2023-04-01&rft.issn=0916-9636&rft.eissn=1348-4214&rft.volume=46&rft.issue=4&rft.spage=1009&rft.epage=1019&rft_id=info:doi/10.1038%2Fs41440-023-01195-0&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s41440_023_01195_0
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0916-9636&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0916-9636&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0916-9636&client=summon